PRESS STATEMENTS09.12.2019 Catalia Health and Pfizer collaborate to better understand patient journeys using artificial intelligence and via robot wellness coach09.06.2019 Hospira, Inc., Issues A Voluntary Nationwide Recall for one lot of BACTERIOSTATIC WATER for Injection, USP, due to a Potential Lack of Sterility Assurance.09.01.2019 Findings Released from NAXOS, a French Real-World Data Analysis and the Largest Real-World Data Analysis on Oral Anticoagulant Effectiveness and Safety in Europe Among Patients with Non-Valvular Atrial Fibrillation08.14.2019 Pfizer Inc. Issues A Voluntary Nationwide Recall For 2 Lots of RELPAX® (eletriptan hydrobromide) 40 mg Tablets Due to Potential Microbiological Contamination of Non-Sterile Products07.26.2019 Pfizer Statement on Update to XELJANZ® (tofacitinib) Prescribing Information in the United States05.17.2019 Pfizer confirms initiation of EU review of Tofacitinib with interim recommendations04.26.2019 Pfizer Inc. Issues A Voluntary Nationwide Consumer Level Recall of One Lot of ThermaCare® Back Pain Therapy HeatWraps, up to 16HR pain relief, Due To Out of Specification Results for High Cell Temperature03.18.2019 Hospira, Inc. Issues A Voluntary Nationwide Recall of 8.4% Sodium Bicarbonate Injection, USP Due To The Presence of Particulate Matter.02.19.2019 Pfizer Announces Modification To Ongoing Tofacitinib FDA Post-Marketing Requirement Study In Patients With Rheumatoid Arthritis11.26.2018 Pfizer Inc. Issues A Voluntary Nationwide Consumer Level Recall Of Six Lots Of ThermaCare® HeatWraps Due To Leaking Wraps with the Potential For Skin Injuries11.16.2018 Pfizer Provides Transparency On Drug Prices In The U.S. 90 Percent Of Company’s Prices Will Remain Unchanged11.11.2018 Real-World Evidence on Patients Aged 80 and Older Presented From ARISTOPHANES, the Largest Real-World Data Study Evaluating Oral Anticoagulants Among Patients with Non-Valvular Atrial Fibrillation11.09.2018 Data From Phase 2 PALLET Study of IBRANCE® (palbociclib)in Early Breast Cancer to be Presented at San Antonio Breast Cancer Symposium10.18.2018 Pfizer Announces Initiation of Phase 3 Trial of Tofacitinib in Patients with Ankylosing Spondylitis09.12.2018 Terry Bradshaw and Pfizer Encourage Boomers to Understand Their Risk for Pneumococcal Pneumonia and Take Action to Help Prevent It08.27.2018 Pfizer, Inc. Issues A Voluntary Nationwide Recall Of One Lot Of Children’s Advil® Suspension Bubble Gum Flavored 4 FL OZ Bottle08.22.2018 Exact Sciences and Pfizer Enter into U.S. Promotion Agreement for Cologuard®08.21.2018 Important Update on EpiPen® (epinephrine injection, USP) 0.3 mg Auto-Injectors08.20.2018 Bristol-Myers Squibb-Pfizer Alliance ACROPOLIS™ Real-World Data Program Grows to Sample Size of Nearly One Million Lives Worldwide08.08.2018 Important Notice Regarding EpiPen Auto-Injector U.S. SupplyPaginationFirst page« FirstPrevious page‹ Previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8Next pageNext ›Last pageLast »Press Release ArchivePress StatementsPodcastsScience Will WinThe Antigen PodcastThe Antigen Podcast Season 1The Antigen Podcast Episode 1: Vaccines 101The Antigen Podcast Episode 2: The History of VaccinesThe Antigen Podcast Episode 3: Global Perspectives, Barriers & SolutionsThe Antigen Podcast Episode 4: Vaccine Hesitancy Part 1The Antigen Podcast Episode 5: Vaccine Hesitancy Part 2The Antigen Podcast Episode 6: Vaccine Politics, Policy & AdvocacyThe Antigen Podcast Episode 7: Innovations in the Vaccine LandscapeThe Antigen Podcast Episode 8: What's Next?The Antigen Podcast Season 2The Antigen Podcast Episode 1: #COVID19 Looking Back to Look ForwardThe Antigen Podcast Episode 2: #COVID19 What Do We Do in the Meantime?The Antigen Podcast Episode 3: #COVID19 The Quest for a VaccineThe Antigen Podcast Episode 4: #COVID19 Teamwork Makes the Dream WorkDiverse Perspectives Podcastmenopause: unmutedHemcastContact Media RelationsPress Kits & DownloadsCompany Press KitPfizer Oncology Press KitPSA NarrativeRare Disease Gene Therapy Press KitATTR-Amyloidosis Press KitUC NarrativeEczema Inside Out Press KitOnline Pfizer Press KitCompany Press KitView the Pfizer Company Press KitPress StatementsView Pfizer's latest press statements Related ArticlesOur ProductsShot of a Lifetime: How Two Pfizer Manufacturing Plants Upscaled…Our ProductsShot of a Lifetime: How Pfizer Developed its Own Raw Materials…Our ProductsShot of a Lifetime: How Pfizer and BioNTech Developed and…Our ProductsShot of a Lifetime: How Pfizer is Partnering with CMOs to…Your HealthWhy Raising Health Literate Children Is ImportantOur PurposeReasons to Reject H.R. 3Your HealthThe Truth About COVID-19 and Black FungusOur ScienceContinuing to Follow the Science: An Open Letter from Pfizer…Our PurposeHow We’re Partnering to Improve Health Outcomes for Black YouthOur PurposeWhy Foreign Drug Pricing Policies Don’t WorkOur PeopleRamcess Jean-Louis Is Ready to Build on Pfizer’s Longtime…Our PurposeThrough Public-Private Partnership, Scientists are Working to…Our PurposeAiming for Equity: Assessing Pfizer's Ongoing Commitment to…Our PeopleThanking John Young for His Years of Service to Pfizer – and to…Our PurposeIncreased Access to Biosimilars Could Save the U.S. Healthcare…Your HealthTranslating Technical Language into Plain Language for Clinical…Our PurposeHow 10 Biopharma Companies are Working Together to Bring…Our PeopleView for the FutureYour HealthA "Ticklist" For Staying Safe While Spending Time…Your HealthHealth Screenings Every African American Man Should KnowYour HealthEmpowering Patients by Closing the Health Literacy GapShowHide
![iStock-1199449498_380x300[1].jpg](https://cdn.pfizer.com/pfizercom/styles/style_300_170/s3/2021-09/iStock-1199449498_380x300%5B1%5D.jpg?pYyJpQdhyvaU22v13JPyau8ro2rGk0CR&itok=pJGCW7Vt)
